TY - JOUR T1 - Role of vitamin D in risk factors of patients with type 2 diabetes mellitus JO - Medicina Clínica (English Edition) T2 - AU - Zhang,Qingqing AU - Wu,Yucheng AU - Lu,Yu AU - Fei,Xiaoqiang SN - 23870206 M3 - 10.1016/j.medcle.2019.04.037 DO - 10.1016/j.medcle.2019.04.037 UR - https://www.elsevier.es/en-revista-medicina-clinica-english-edition--462-articulo-role-vitamin-d-in-risk-S238702062030036X AB - Introduction and objectivesPrevious observational studies have suggested that low vitamin D status is associated with high circulating C-reactive protein levels, as well as other plasma inflammatory cytokines. However, there is no study to explore the relationship between vitamin D status and Lp-PLA2, a new biomarker of vascular-specific inflammation. The aim of this study was to examine the association between vitamin D status and circulating Lp-PLA2 levels in subjects with type 2 diabetes mellitus. Material and methodsThis descriptive cross-sectional study enrolled diabetic subjects who underwent physical examination at Taizhou People's Hospital between August 2016 and January 2017. Blood pressure, anthropometry, metabolic profiles, serum 25(OH)D levels and Lp-PLA2 mass levels were measured in all participants. ResultsA total of 196 participants were recruited into this study. The vitamin D insufficiency group had higher serum LP-PLA2 levels than the vitamin D sufficiency group (t=−2.765, p=.005). A significant negative correlation was noted between Lp-PLA2 and 25(OH)D in the vitamin D insufficiency group (r=−0.364, p=0.009). However, no significant relationship between serum Lp-PLA2 concentration and 25(OH)D levels was observed in subjects with vitamin D sufficiency. ConclusionsFrom this cohort of patients with type 2 diabetes, regardless of traditional cardiovascular risk factors, we observed a statistically significant inverse relation between Lp-PLA2 and 25(OH)D at levels <30ng/mL. ER -